...
机译:6-甲氧基乙基氨基-numonafide抑制肝细胞癌异种移植物生长作为单一药物和与索拉非尼联合使用
Zhejiang Univ, Affiliated Hosp 1, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab;
Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, 303 E Chicago Ave, Chicago, IL 60614 USA;
Northwestern Univ, Dev Therapeut Core, Chicago, IL 60614 USAChinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, State Key Lab Drug Res, ShanghaiNIDDK, NIH, Bethesda, MD USANorthwestern Univ, Dept Anesthesiol, Feinberg Sch Med, Chicago, IL 60614 USANorthwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60614 USA;
MEAN; HCC therapeutic; combination treatment; C-MYC inhibition;
机译:Efficacy and Safety of Bavituximab in Combination with Sorafenib in Advanced Hepatocellular Carcinoma: A Single-Arm, Open-Label, Phase II Clinical Trial
机译:Efficacy and safety of sorafenib in combination with gemcitabine in patients with advanced hepatocellular carcinoma: A multicenter, open-label, single-arm phase II study
机译:Sustained complete remission of metastatic hepatocellular carcinoma with single agent sorafenib
机译:ENmD-1198, a novel tubulin-binding agent reduces HIF-1alpha and sTaT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization